Dr. Kenney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
60 Hamilton Street
Cambridge, MA 02139Phone+1 650-766-7709- Is this information wrong?
Education & Training
- University of California (San Diego) Medical CenterResidency, Neurology, 2000 - 2003
- Boston University Medical CenterInternship, Internal Medicine, 1999 - 2000
- Boston University School of MedicineClass of 1999
- University of California, San DiegoBA, Biochemistry, 1988 - 1992
Certifications & Licensure
- MA State Medical License 2008 - 2024
- CA State Medical License 2001 - 2012
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Top-ranking Abstract-Congress Parkinson's Disease and Movement Disorders, 2006
- National Center of Leadership in Academic Medicine 2004
- Chief Resident in Neurology UCSD (University of California, San Diego) Medical Center, 2002
Publications & Presentations
PubMed
- 16 citationsAssessment of gait and balance impairment in people with spinocerebellar ataxia using wearable sensors.He Zhou, Hung Nguyen, Ana Enriquez, Louie Morsy, Michael Curtis, Timothy Piser, Christopher Kenney, Christopher D. Stephen, Anoopum S. Gupta, Jeremy D. Schmahmann, Ash...> ;Neurological Sciences. 2021 Oct 19
- 1 citationsAdverse event reporting in clinical trials in Parkinson's Disease: Time for change.C. Warren Olanow, Christopher Kenney, Stephen Bandak, Karl Kieburtz> ;Movement Disorders. 2018 Nov 1
- 132 citationsAssessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.Anthony H.V. Schapira, Susan H. Fox, Robert A. Hauser, Joseph Jankovic, Wolfgang H. Jost, Christopher Kenney, Jaime Kulisevsky, Rajesh Pahwa, Werner Poewe, R. Anand> ;JAMA Neurology. 2017 Feb 1
- Join now to see all
Journal Articles
- Pharmacokinetics and Metabolism of [14C]-Tozadenant (SYN-115), a Novel A2a receptor antagonist ligand, in Healthy volunteersMancel V, Mathy FX, Boulanger P, English S, Croft M, Kenney C, Knott T, Stockis A Bani M, Xenobiotica, 1/1/2017
- Safinamide as adjunct to levodopa in Parkinson's disease patients with motor fluctuations: A 24-week randomized, double-blind, placebo-controlled trialSchapira A, Fox S, Hauser R, Jankovic J, Jost W, Kenney C, Kulisevsky J, Pahwa R, Poewe W, Anand R, JAMA Neurology, 1/1/2017
- Two randomized phase 2 studies of mavoglurant in Parkinson's patients with L-dopa-induced dyskinesiasTrenkwalder C, Stocchi F, Poewe W, Dronamraju N, Kenney C, Shah A, von Raison F, Graf A, Mov Disord, 1/1/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Fox Insight: A Large-scale Web-enabled Parkinson's Disease Study.Chahine L, Caspell-Garcia C, McLaughlin L, Marras C, Standaert D, Ravina B, Kenney C, Chowdhury S, Sherer T, Kopil C, 69th Annual American Academy of Neurology Meeting, Boston, MA, 1/22/2017
- Adverse Event Reporting in Clinical Trials - Time for Change.Kenney C, Kieburtz K, Olanow CW, Bandak S, ASENT 19th Annual Meeting, Rockville, MD, 1/14/2017
- Efficacy of Tozadenant in Animal Models of Non-Motor Symptoms of Parkinson's Disease.Kostrub C, Kenney C, Riemer C, Prinssen E, Flohr A, and Moreau J, 21st International Congress on Parkinson's Disease and Movement Disorders, Vancouver, BC, 1/4/2017
- Join now to see all
Press Mentions
- Xenon Pharmaceuticals : Strengthens Leadership Team with Appointment of Dr. Christopher Kenney as Chief Medical Officer (Form 8-K)August 23rd, 2021
Hospital Affiliations
- South Shore HospitalSouth Weymouth, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: